Karyopharm Therapeutics reported $2.31M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 9.44M 4.97M
Amgen AMGN:US $ 1277M 119M
Avrobio Inc AVRO:US 2.03M 669K
Bristol Myers Squibb BMY:US $ 3609M 637M
Eli Lilly And LLY:US $ 1597.8M 41.8M
Enanta Pharmaceuticals ENTA:US $ 5.9M 0.2M
Epizyme EPZM:US $ 7.3M 1.94M
Karyopharm Therapeutics KPTI:US $ 2.31M 731K
Macrogenics MGNX:US $ 9.82M 528K
Mirati Therapeutics MRTX:US $ 23.87M 4.27M
Nektar Therapeutics NKTR:US $ 19.7M 2.73M
Novartis NOVN:VX 4.81B 229M
Novartis NVS:US $ 4811M 229M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Sangamo Biosciences SGMO:US 10.13M 1.51M
Takeda 4502:JP Y 320645M 23193M
Ultragenyx Pharmaceutical RARE:US $ 21.79M 6.05M
Xencor XNCR:US $ 7.11M 0.55M
YTE INCY:US $ 122.1M 37.04M